載入...
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir: ACTG A5224 s, A5202 substudy
BACKGROUND: The effect of specific antiretrovirals on inflammation is unclear. METHODS: A5224 s was a substudy of A5202, which randomized HIV-infected treatment-naïve subjects to blinded abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC) with open-label efavirenz (EFV) or atazanavir/...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3560932/ https://ncbi.nlm.nih.gov/pubmed/22546988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e328354f4fb |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|